Neuroglobin and Alzheimer's dementia: Genetic association and gene expression changes

Neurobiology of Aging

Volumn 31, Issue 11, 2010, Pages 1835-1842

  Szymanski, Megan ^a   Wang, Ruihua ^a   Fallin, M Danielle ^b   Bassett, Susan S ^a   Avramopoulos, Dimitrios ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; Dementia; Gene expression; Neuroglobin

Indexed keywords

AMYLOID PROTEIN; NEUROGLOBIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 14Q; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; UPREGULATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; FOLLOW-UP STUDIES; GLOBINS; HALLUCINATIONS; HUMANS; LOD SCORE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; REFERENCE VALUES; SEX FACTORS; TEMPORAL LOBE;

EID: 77956915887     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.10.003     Document Type: Article

References (63)

1. Avramopoulos D., Fallin M.D., Bassett S.S. Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 132(1):9-13.
2. Bamberger M.E., Landreth G.E. Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 2002, 8(3):276-283.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
4. Bertram L., Tanzi R.E. The current status of Alzheimer's disease genetics: what do we tell the patients?. Pharmacol. Res. 2004, 50(4):385-396.
5. Blacker D., Bertram L., Saunders A.J., Moscarillo T.J., Albert M.S., Wiener H., Perry R.T., Collins J.S., Harrell L.E., Go R.C., Mahoney A., Beaty T., Fallin M.D., Avramopoulos D., Chase G.A., Folstein M.F., McInnis M.G., Bassett S.S., Doheny K.J., Pugh E.W., Tanzi R.E. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 2003, 12(1):23-32.
6. Brown A.M., Gordon D., Lee H., Caudy M., Haroutunian V., Blass J.P. Substantial linkage disequilibrium across the dihydrolipoyl succinyltransferase gene region without Alzheimer's disease association. Neurochem. Res. 2004, 29(3):629-635.
7. Brunori M., Vallone B. Neuroglobin, seven years after. Cell. Mol. Life Sci. 2007, 64(10):1259-1268.
8. Burmester T., Weich B., Reinhardt S., Hankeln T. A vertebrate globin expressed in the brain. Nature 2000, 407(6803):520-523.
9. Cecchi C., Fiorillo C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., Nassi P., Liguri G. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic. Biol. Med. 2002, 33(10):1372-1379.
10. Cuvillier O. Sphingosine in apoptosis signaling. Biochim.. Biophys. Acta 2002, 1585(2-3):153-162.
11. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 2000, 66(1):196-204.
12. Devi G., Ottman R., Tang M.X., Marder K., Stern Y., Mayeux R. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch. Neurol. 2000, 57(1):72-77.
13. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 2008, 66(2):87-98.
14. Fan J.B., Chee M.S., Gunderson K.L. Highly parallel genomic assays. Nat. Rev. Genet. 2006, 7(8):632-644.
15. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., Pasternak S., Wheeler D.A., Willis T.D., Yu F., Yang H., Zeng C., Gao Y., Hu H., Hu W., Li C., Lin W., Liu S., Pan H., Tang X., Wang J., Wang W., Yu J., Zhang B., Zhang Q., Zhao H., Zhao H., Zhou J., Gabriel S.B., Barry R., Blumenstiel B., Camargo A., Defelice M., Faggart M., Goyette M., Gupta S., Moore J., Nguyen H., Onofrio R.C., Parkin M., Roy J., Stahl E., Winchester E., Ziaugra L., Altshuler D., Shen Y., Yao Z., Huang W., Chu X., He Y., Jin L., Liu Y., Shen Y., Sun W., Wang H., Wang Y., Wang Y., Xiong X., Xu L., Waye M.M., Tsui S.K., Xue H., Wong J.T., Galver L.M., Fan J.B., Gunderson K., Murray S.S., Oliphant A.R., Chee M.S., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Olivier J.F., Phillips M.S., Roumy S., Sallee C., Verner A., Hudson T.J., Kwok P.Y., Cai D., Koboldt D.C., Miller R.D., Pawlikowska L., Taillon-Miller P., Xiao M., Tsui L.C., Mak W., Song Y.Q., Tam P.K., Nakamura Y., Kawaguchi T., Kitamoto T., Morizono T., Nagashima A., Ohnishi Y., Sekine A., Tanaka T., Tsunoda T., Deloukas P., Bird C.P., Delgado M., Dermitzakis E.T., Gwilliam R., Hunt S., Morrison J., Powell D., Stranger B.E., Whittaker P., Bentley D.R., Daly M.J., de Bakker P.I., Barrett J., Chretien Y.R., Maller J., McCarroll S., Patterson N., Pe'er I., Price A., Purcell S., Richter D.J., Sabeti P., Saxena R., Schaffner S.F., Sham P.C., Varilly P., Altshuler D., Stein L.D., Krishnan L., Smith A.V., Tello-Ruiz M.K., Thorisson G.A., Chakravarti A., Chen P.E., Cutler D.J., Kashuk C.S., Lin S., Abecasis G.R., Guan W., Li Y., Munro H.M., Qin Z.S., Thomas D.J., McVean G., Auton A., Bottolo L., Cardin N., Eyheramendy S., Freeman C., Marchini J., Myers S., Spencer C., Stephens M., Donnelly P., Cardon L.R., Clarke G., Evans D.M., Morris A.P., Weir B.S., Tsunoda T., Mullikin J.C., Sherry S.T., Feolo M., Skol A., Zhang H., Zeng C., Zhao H., Matsuda I., Fukushima Y., Macer D.R., Suda E., Rotimi C.N., Adebamowo C.A., Ajayi I., Aniagwu T., Marshall P.A., Nkwodimmah C., Royal C.D., Leppert M.F., Dixon M., Peiffer A., Qiu R., Kent A., Kato K., Niikawa N., Adewole I.F., Knoppers B.M., Foster M.W., Clayton E.W., Watkin J., Gibbs R.A., Belmont J.W., Muzny D., Nazareth L., Sodergren E., Weinstock G.M., Wheeler D.A., Yakub I., Gabriel S.B., Onofrio R.C., Richter D.J., Ziaugra L., Birren B.W., Daly M.J., Altshuler D., Wilson R.K., Fulton L.L., Rogers J., Burton J., Carter N.P., Clee C.M., Griffiths M., Jones M.C., McLay K., Plumb R.W., Ross M.T., Sims S.K., Willey D.L., Chen Z., Han H., Kang L., Godbout M., Wallenburg J.C., L'Archeveque P., Bellemare G., Saeki K., Wang H., An D., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L., Shi M., Spiegel J., Sung L.M., Zacharia L.F., Collins F.S., Kennedy K., Jamieson R., Stewart J. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449(7164):851-861.
16. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
17. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 1998, 55(9):809-815.
18. Gibson G.E., Huang H.M. Oxidative stress in Alzheimer's disease. Neurobiol. Aging 2005, 26(5):575-578.
19. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349(6311):704-706.
20. Greenberg D.A., Jin K., Khan A.A. Neuroglobin: an endogenous neuroprotectant. Curr. Opin. Pharmacol. 2008, 8(1):20-24.
21. Herold S., Fago A., Weber R.E., Dewilde S., Moens L. Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress. J. Biol. Chem. 2004, 279(22):22841-22847.
22. Jarvik G., Larson E.B., Goddard K., Schellenberg G.D., Wijsman E.M. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am. J. Hum. Genet. 1996, 58(1):191-200.
23. Jin K., Mao X.O., Xie L., Khan A.A., Greenberg D.A. Neuroglobin protects against nitric oxide toxicity. Neurosci. Lett. 2008, 430(2):135-137.
24. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 1999, 8(2):237-245.
25. Khan A.A., Mao X.O., Banwait S., Jin K., Greenberg D.A. Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(48):19114-19119.
26. Khan A.A., Ou Mao X., Banwait S., Dermardirossian C.M., Bokoch G.M., Jin K., Greenberg D.A. Regulation of hypoxic neuronal death signaling by neuroglobin. FASEB J. 2008.
27. Khan A.A., Sun Y., Jin K., Mao X.O., Chen S., Ellerby L.M., Greenberg D.A. A neuroglobin-overexpressing transgenic mouse. Gene 2007, 398(1-2):172-176.
28. Khan A.A., Wang Y., Sun Y., Mao X.O., Xie L., Miles E., Graboski J., Chen S., Ellerby L.M., Jin K., Greenberg D.A. Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(47):17944-17948.
29. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37(5):495-500.
30. Kunugi H., Nanko S., Ueki A., Isse K., Hirasawa H. DLST gene and Alzheimer's disease. Lancet 1998, 351(9115):1584-1585.
31. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A., Weber J.L., Bird T.D., Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science 1995, 269(5226):970-973.
32. Li H.S., Wang D., Shen Q., Schonemann M.D., Gorski J.A., Jones K.R., Temple S., Jan L.Y., Jan Y.N. Inactivation of Numb and Numblike in embryonic dorsal forebrain impairs neurogenesis and disrupts cortical morphogenesis. Neuron 2003, 40(6):1105-1118.
33. Li L., Zhang X., Yang D., Luo G., Chen S., Le W. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol. Aging 2007.
34. Li R.C., Pouranfar F., Lee S.K., Morris M.W., Wang Y., Gozal D. Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury. Neurobiol. Aging 2007.
35. Ma Q., Chan P., Yang J. [Association between DLST gene polymorphism and Alzheimer's disease]. Zhonghua Yi Xue Za Zhi 2001, 81(20):1246-1248.
36. Matsushita S., Arai H., Yuzuriha T., Kato M., Matsui T., Urakami K., Higuchi S. No association between DLST gene and Alzheimer's disease or Wernicke-Korsakoff syndrome. Neurobiol. Aging 2001, 22(4):569-574.
37. McGeer P.L., Rogers J., McGeer E.G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 2006, 9(3 Suppl.):271-276.
38. Miech R.A., Breitner J.C., Zandi P.P., Khachaturian A.S., Anthony J.C., Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 2002, 58(2):209-218.
39. Nakano K., Ohta S., Nishimaki K., Miki T., Matuda S. Alzheimer's disease and DLST genotype. Lancet 1997, 350(9088):1367-1368.
40. Nunomura A., Castellani R.J., Zhu X., Moreira P.I., Perry G., Smith M.A. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65(7):631-641.
41. Peers C., Pearson H.A., Boyle J.P. Hypoxia and Alzheimer's disease. Essays Biochem. 2007, 43:153-164.
42. Pericak-Vance M.A., Grubber J., Bailey L.R., Hedges D., West S., Santoro L., Kemmerer B., Hall J.L., Saunders A.M., Roses A.D., Small G.W., Scott W.K., Conneally P.M., Vance J.M., Haines J.L. Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerontol. 2000, 35(9-10):1343-1352.
43. Petersen P.H., Zou K., Hwang J.K., Jan Y.N., Zhong W. Progenitor cell maintenance requires numb and numblike during mouse neurogenesis. Nature 2002, 419(6910):929-934.
44. Prince J.A., Feuk L., Sawyer S.L., Gottfries J., Ricksten A., Nagga K., Bogdanovic N., Blennow K., Brookes A.J. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 2001, 9(6):437-444.
45. Pruitt K.D., Tatusova T., Maglott D.R. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2007, 35(Database issue):D61-D65.
46. Reynolds A., Laurie C., Mosley R.L., Gendelman H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82:297-325.
47. Schmidt M., Giessl A., Laufs T., Hankeln T., Wolfrum U., Burmester T. How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. J. Biol. Chem. 2003, 278(3):1932-1935.
48. Seshadri S., Wolf P.A., Beiser A., Au R., McNulty K., White R., D'Agostino R.B. Lifetime risk of dementia and Alzheimer's disease: the impact of mortality on risk estimates in the Framingham Study. Neurology 1997, 49(6):1498-1504.
49. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375(6534):754-760.
50. Sheu K.F., Brown A.M., Kristal B.S., Kalaria R.N., Lilius L., Lannfelt L., Blass J.P. A DLST genotype associated with reduced risk for Alzheimer's disease. Neurology 1999, 52(7):1505-1507.
51. Shi Q., Gibson G.E. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2007, 21(4):276-291.
52. Shimohama S. Apoptosis in Alzheimer's disease-an update. Apoptosis 2000, 5(1):9-16.
53. Soucek T., Cumming R., Dargusch R., Maher P., Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 2003, 39(1):43-56.
54. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(5):1977-1981.
55. Sun Y., Jin K., Mao X.O., Xie L., Peel A., Childs J.T., Logvinova A., Wang X., Greenberg D.A. Effect of aging on neuroglobin expression in rodent brain. Neurobiol. Aging 2005, 26(2):275-278.
56. Sun Y., Jin K., Mao X.O., Zhu Y., Greenberg D.A. Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(26):15306-15311.
57. Sun Y., Jin K., Peel A., Mao X.O., Xie L., Greenberg D.A. Neuroglobin protects the brain from experimental stroke in vivo. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(6):3497-3500.
58. Takuma K., Yan S.S., Stern D.M., Yamada K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. J. Pharmacol. Sci. 2005, 97(3):312-316.
59. The_International_HapMap_Consortium, 2003. The International HapMap Project. Nature 426(6968), 789-796.
60. Waring S.C., Rosenberg R.N. Genome-wide association studies in Alzheimer disease. Arch. Neurol. 2008, 65(3):329-334.
61. Weisman D., Hakimian E., Ho G.J. Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam. Horm. 2006, 74:505-530.
62. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12(9):1005-1015.
63. Zhu X., Smith M.A., Honda K., Aliev G., Moreira P.I., Nunomura A., Casadesus G., Harris P.L., Siedlak S.L., Perry G. Vascular oxidative stress in Alzheimer disease. J. Neurol. Sci. 2007, 257(1-2):240-246.